Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Nashville,, TN
SEC filing record 1 source field available
Fiscal year end
31 December
CUMBERLAND PHARMACEUTICALS INC has filed 1,032 SEC EDGAR filings since 02 May 2002

SEC filing history

Showing 426-450 of 959 matching filings.

Per page
25
Current page
18
4

FORM 4 SUBMISSION

Filing date
17 Apr 2020
Reporting date
23 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Apr 2020
Reporting date
18 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Apr 2020
Reporting date
18 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Apr 2020
Reporting date
18 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Apr 2020
Reporting date
18 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Apr 2020
Reporting date
18 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33637

DEF 14A

Filing date
20 Mar 2020
Reporting date
05 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K

Filing date
18 Mar 2020
Reporting date
18 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85205

SC 13G/A filing

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85205

SC 13G/A filing

Filing date
13 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85205

SCHEDULE 13G/A

Filing date
12 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85205

SC 13G

Filing date
07 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K

Filing date
10 Jan 2020
Reporting date
10 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K CLINIGEN PRODUCTS

Filing date
03 Jan 2020
Reporting date
03 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Dec 2019
Reporting date
20 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K

Filing date
06 Dec 2019
Reporting date
06 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Dec 2019
Reporting date
06 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Nov 2019
Reporting date
26 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Nov 2019
Reporting date
26 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Nov 2019
Reporting date
26 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K

Filing date
29 Nov 2019
Reporting date
25 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K

Filing date
12 Nov 2019
Reporting date
12 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Oct 2019
Reporting date
11 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .